AbCellera Biologics Inc (NASDAQ: ABCL) is -49.74% lower on its value in year-to-date trading and has touched a low of $2.34 and a high of $6.05 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABCL stock was last observed hovering at around $2.68 in the last trading session, with the day’s gains setting it 0.19%.
Currently trading at $2.87, the stock is 11.96% and 10.76% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.15 million and changing 7.09% at the moment leaves the stock -23.63% off its SMA200. ABCL registered -34.02% loss for a year compared to 6-month loss of -25.84%. The firm has a 50-day simple moving average (SMA 50) of $2.5911 and a 200-day simple moving average (SMA200) of $3.758125.
The stock witnessed a 4.74% gain in the last 1 month and extending the period to 3 months gives it a -4.65%, and is 10.81% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.08% over the week and 4.80% over the month.
AbCellera Biologics Inc (ABCL) has around 586 employees, a market worth around $845.70M and $33.06M in sales. Profit margin for the company is -463.77%. Distance from 52-week low is 22.91% and -52.60% from its 52-week high. The company has generated returns on investments over the last 12 months (-13.02%).
with sales reaching $7.95M over the same period.The EPS is expected to grow by 10.68% this year, but quarterly earnings will post -11.60% year-over-year. Quarterly sales are estimated to shrink -32.90% in year-over-year returns.
AbCellera Biologics Inc (ABCL) Top Institutional Holders
210.0 institutions hold shares in AbCellera Biologics Inc (ABCL), with institutional investors hold 53.30% of the company’s shares. The shares outstanding are 290.82M, and float is at 206.59M with Short Float at 8.26%. Institutions hold 38.35% of the Float.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 27.53 million shares valued at $81.48 million. The investor’s holdings represent 9.4033% of the ABCL Shares outstanding. As of 2024-06-30, the second largest holder is BAILLIE GIFFORD & CO with 21.91 million shares valued at $64.86 million to account for 7.4852 of the shares outstanding. The other top investors are VOYA INVESTMENT MANAGEMENT LLC which holds 10.63 million shares representing 3.6322% and valued at over $31.47 million, while CAPITAL WORLD INVESTORS holds 1.817 of the shares totaling 5.32 million with a market value of $15.74 million.
AbCellera Biologics Inc (ABCL) Insider Activity
#####
